2 unknown. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Unknown 2 |
Follow Rabies: new trials by email Literature Review of Rabies trials Research Report on Rabies
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine (Sinopharm BBIBP-CorV) Coadministered With Rabies Vaccine coadministration, COVID-19 vaccine, rabies vaccine - COVID-19, Rabies | Phase 4 | Unknown | China National Biotec Group Company Limited | 360 | 2022-07-21 | 2022-07-29 |
| Persistence of Rabies Antibody 1-5 Years After the Post-exposure Prophylaxis With Vero Cell Antirabies Vaccine and Antibody Response to a Single Booster Dose Rabies vaccine, manufactured by ChengDa - Rabies | Phase 4 | Unknown | Peking University People's Hospital | 160 | 2010-05-01 | 2010-08-02 |
COVID-19 (1)
Infections (2) · Mononegavirales Infections (2) · RNA Virus Infections (2) · Rhabdoviridae Infections (2) · Virus Diseases (2) · Coronaviridae Infections (1) · Coronavirus Infections (1) · Lung Diseases (1) · Nidovirales Infections (1) · Pneumonia (1) · Pneumonia, Viral (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1)
Rabies Vaccines (2) · COVID-19 Vaccines (1)
China National Biotec Group Company Limited (1) · Peking University People's Hospital (1)
China (2)
Ruizhi Zhang (1)